semaglutide shut down Woman shares journey of weight loss and gain after using September 2, 2025: U.S. compounding

Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535.

Anderson, FASAE, CAE, IOM President & Chief Executive Officer Date: June 4, 2026 Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide

ChewSmart GLP-1 Patches Craving Control, Made Effortless Steady-release patches to support appetite regulation, energy, and weight balancenaturally and without pills

Type 2 diabetes mellitus (T2DM) is a complex chronic disease characterized by progressive -cell dysfunction and insulin resistance

Use our TDEE calculator to find your Total Daily Energy Expenditure - discover how many calories you burn each day and get personalized health insights.